← All indications
Erythema
Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
Subtype terms (8)
More specific conditions that are subtypes of Erythema in the MeSH hierarchy.
- Erythema Ab Igne
- Erythema Chronicum Migrans
4 drugs approved
- Erythema Induratum
- Erythema Infectiosum
2 drugs (1 approved, 1 experimental)
- Erythema Multiforme
5 drugs approved
- Erythema Nodosum
- Erythrokeratodermia Variabilis
- Sweet Syndrome
1 drug experimental
Drugs by status
Approved for this indication (2)
Phase 4 trials (7)
Phase 3 trials (2)
Phase 2 trials (10)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (51)
- Actavis
- Bausch & Lomb
- Perrigo
- Allergan
- ORA, Inc.
- Dermatology, Laser & Vein Specialists of the Carolinas
- Tennessee Clinical Research Center
- University of California, San Francisco
- Windsor Clinical Research
- Philadelphia Institute of Dermatology
- The Education & Research Foundation, Inc.
- Oregon Medical Research Center
- Hamzavi Dermatology
- PMG Research
- Minnesota Clinical Study Center
- Premier Research Group
- Palmetto Clinical Trial Services, LLC
- Burke Pharmaceutical Research
- Watson Pharmaceuticals
- Progressive Clinical Research
- Innovaderm
- Kirk Barber Research Inc.
- Grekin Skin Institute
- J&S Studies Inc.
- Nexus Clinical Research
- Oregon Dermatology and Research Center
- Dermatology Consulting Services, High Point NC
- Lynderm Research Inc
- Arlington Center for Dermatology
- Windsor Dermatology
- +21 more
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (24)
- United States Army
- University of London
- Harvard University
- Henry Ford Health System
- Higher School of Applied Sciences (VIST)
- New York University
- The Leprosy Mission Bangladesh
- University of California, Davis
- University of California, Los Angeles
- University of Vienna
- Department of Defense
- Defense Health Agency
- Damien Foundation Bangladesh
- Valens Int. d.o.o., Slovenija
- European Regional Development Fund
- Alert Hospital, Ethiopia
- Government of Slovenia
- Dr. Soetomo General Hospital
- Oswaldo Cruz Foundation
- Skin Laser & Surgery Specialists
- Dermatologija Bartenjev Rogl
- The Leprosy Mission Trust India (TLMTI)
- Leprosy Research Initiative
- Bombay Leprosy Project, India